Your session is about to expire
← Back to Search
Procedure
ExAblate Transcranial System for Brain Tumor
N/A
Waitlist Available
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Size of the targeted portion of the tumor (i.e. prescribed ROT) is less than 2.5 cm in diameter (8 cm3 in volume). The non-targeted tumor tissue may exceed the targeted volume.
OR Patients with metastatic brain cancer that has progressed despite prior radiotherapy and local therapy is requested by the oncologist. This treatment will be offered as an option for those patients where surgery is not indicated and discussed with the potential options for repeat radiotherapy or salvage radiosurgery by the multidisciplinary team.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of exablate procedure
Awards & highlights
Study Summary
This trial will test whether transcranial MRI-guided focused ultrasound surgery is safe and effective in treating brain tumors.
Eligible Conditions
- Brain Tumor
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at the time of exablate procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of exablate procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Evaluate Safety of ExAblate Transcranial Device
Trial Design
1Treatment groups
Experimental Treatment
Group I: ExAblate Transcranial DeviceExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ExAblate Transcranial System
2011
N/A
~30
Find a Location
Who is running the clinical trial?
InSightecLead Sponsor
88 Previous Clinical Trials
3,694 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger